20513 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION
#2PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASE, NEURONAL MIGRATION PROMOTER, AND USE THEREOF
#3PERIPHERALLY RESTRICTED GABA POSITIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND OTHER AILMENTS OF THE PERIPHERAL NERVOUS SYSTEM
#4METHOD OF TREATING INFLUENZA A
#5MICROBIOTA IMPROVING AGENT
#6COMPOSITION FOR CONTROLLING GROWTH OF BACTERIA IN THE INTESTINAL TRACT AND USE THEREOF
#7PHARMACEUTICAL COMPOSITION FOR IMPROVING LIFE QUALITY OF ELDERLY PEOPLE ON BASIS OF VITAMIN K2, PREPARATION METHOD THEREFOR AND USE THEREOF
#8NEW GLYCOSIDE COMPOUND AND PREPARATION PROCESS THEREOF
#9SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING INFECTIONS IN FISH
#10COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#11BIOLOGICALLY COMPATIBLE, BIOFILM DISRUPTING COMPOSITION AND METHODS
#12FRACTIONS OF, AND MOLECULES RELEASED IN, PROTEIN RICH PLASMA WHICH INHIBIT IMMUNE RESPONSES AND REDUCE INFLAMMATION, AND METHODS OF OBTAINING
#13APPLICATIONS OF ANALOGS OR DERIVATIVES OF SIALIC ACIDS
#14MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#15NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF
#16VIRAL RECEPTOR BOUND WITH SIALIC ACID COMPOUNDS
#17COMPOSITIONS FOR RAISING NAD LEVELS AND METHODS AND USES THEREOF
#18SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION
#19Process for the Purification of L-Fucose from a Fermentation Broth
#20CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS
#21THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS
#22COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR OTHER NEGATIVELY CHARGED MOLECULES
#23METHOD OF TREATING INFLUENZA A
#24METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF
#25Sialic acid compositions for the use of inhibiting and treating coronavirus infection
#26SYNTHETIC COMPOSITION FOR TREATING METABOLIC DISORDERS
#27METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS
#28COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#29COMPOSITIONS FOR IMPROVING BRAIN HEALTH AND MEMORY
#30ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
#31SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS
#32Treatment of Glycosylation Deficiency Diseases
#33COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
#34Carbohydrate composition as pharmaceutical ingredient and use thereof
#35COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#36CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS
#37Viral receptor bound with sialic acid compounds
#38COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#39Neutralizing anti-influenza A antibodies and uses thereof
#40IMMUNOGENIC COMPOSITIONS CONTAINING N-GLYCOL YLNEURAMINIC ACID BEARING NANOPARTICLES
#41TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS
#42VEGF Antagonist Formulations
#43MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#44CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN DOSING REGIMENS
#45Use of mannuronic diacid composition in treatment of diabetes
#46Synthetic composition and method for treating irritable bowel syndrome
#47Maillard reaction products as inhibitors of aggregatibacter actinomycetemcomitans
#48Use of mannuronic diacid composition in treatment of inflammation
#49VEGF Antagonist Formulations
#50USE OF LACTULOSE IN THE TREATMENT OF AUTISM
#51N-ACETYLNEURAMINIC ACID COMPOSITIONS AND METHODS OF USE
#52METHODS OF REDUCING AGGREGATION OF IL-1RA
#53NGNA compositions and methods of use
#54Citrate buffered VEGF antagonist formulations
#55COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#56Synthetic composition for treating metabolic disorders
#57Method of treating influenza A
#58Process for the purification of L-fucose from a fermentation broth
#59Process for purification of a sialic acid from a fermentation broth
#60COMPOSITIONS THAT METABOLIZE OR SEQUESTER FREE SUGAR MONOMERS AND USES THEREOF
#61Sialidase inhibitors and preparation thereof
#62Neutralizing anti-influenza A antibodies and uses thereof
#63SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS
#64Formulations of VEG antagonist fusion proteins and method of manufacturing them
#65Glycan-based drugs, therapies and biomarkers
#66N-acetyl mannosammine as a therapeutic agent
#67Use of lactulose in the treatment of autism
#68Compositions and Methods for Treating Diabetes
#69Extract and formulation including extract
#70NUTRITIONAL SUPPLEMENT FOR INCREASING CELLULAR LEVELS OF N-ACETYLNEURAMINATE
#71Calcium gluconate solutions in flexible containers
#72Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction
#73Medicament used for treating hypertension
#74Medicament for use in treating cardiovascular and cerebrovascular diseases
#75Medicament for use in treating fatty liver, hepatitis and cirrhosis
#76Medicament for use in treating gout
#77Medicament for treating uremia and proteinuria
#78Medicament for use in treating diabetes
#79Cannabinoid glycoside prodrugs and methods of synthesis
#80Compounds, Compositions and Methods for Prevention or Treatment of Liver and Lipid-Related Conditions
#81TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS
#82Sialylation-increasing therapies for diseases associated with oxidative stress
#83Adiponectin secretion enhancer
#84Synthetic composition and method for treating irritable bowel syndrome
#85N-acetyl mannosammine as a therapeutic agent
#86STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY
#87Methods for determining the level of hyposialylation of Angptl4
#88Exploiting nutrient deprivation for modulation of glycosylation - research diagnostic, therapeutic, and biotechnology applications
#89COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#90Method of manufacturing VEGF antagonist fusion proteins
#91COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#92Pharmaceuticals for Oral Delivery
#93MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#94SYNTHETIC COMPOSITION AND METHOD FOR PROMOTING MUCOSAL HEALING
#95COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#96METHOD OF DECREASING BLOOD SUGAR
#97Hamamelitannin analogues and uses thereof
#98METHODS AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES
#99METHODS AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES
#100Influenza A H7N9 virus therapies
#101NGNA COMPOSITIONS AND METHODS OF USE
#102Dry-powder peptide medicament
#103Pharmaceuticals for oral delivery
#104Methods of treating coronavirus infection
#105Synthetic composition for treating metabolic disorders
#106Formulation of complex carbohydrate for fodder
#107Methods of modulating the sialylation of Angptl4
#108VEGF specific fusion protein antagonist formulations
#109Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#110Use of lactulose in the treatment of autism
#111Stable VEGF antagonist formulations
#112HYBRID SCFA-HYDROXYL-DERIVATIZED MONOSACCHARIDES, METHODS OF SYNTHESIS, AND METHODS OF TREATING DISORDERS
#113Methods, uses and compositions of Tie2 agonists
#114Composition comprising at least two influenza A virus-neutralizing-binding molecules
#115Glycan-based drugs, therapies and biomarkers
#116Use of a composition comprising avocado perseose in the protection of epidermal stem cells
#117N-ACETYL MANNOSAMMINE AS A THERAPEUTIC AGENT
#118Stabilized compositions of proteins having a free thiol moiety
#119EXTRACT AND FORMULATION INCLUDING EXTRACT
#120Medicinal carbohydrates for treatment of respiratory conditions
#121Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#122Sialic acid derivatives
#123Compositions and methods for reducing or preventing metastasis
#124Stable liquid formulations of dimer VEGF antagonists
#125Use of Neu1 sialidase inhibitors in the treatment of cancer
#126Methods for promoting neuronal development and/or health
#127Methods for promoting neuronal development and/or health
#128Sialic acid dimers
#129ALGAL OMEGA 7 COMPOSITIONS
#130NGNA compositions and methods of use
#131Compositions and methods for utilization of algal compounds
#132Pharmaceuticals for oral delivery
#133Multivalent liposome formulations
#134Cancer therapy
#135Stabilized compositions of proteins having a free thiol moiety
#136Method of increasing lean body mass
#137Use of lactulose in the treatment of autism
#138NGNA composition and methods of use
#139Antitumor agent
#140Substrate reduction therapy
#141MATERNAL SIALIC ACID SUPPLEMENTATION
#142Pyrimidinone compounds and methods for treating influenza
#143Panaxadiol-containing composition
#144Formulations for enhanced bioavailability of orally administered polar agents
#145NGNA compositions and methods of use
#146Materials and methods for prevention and treatment of viral infections
#147Methods and formulations for treating sialic acid deficiencies
#148Stable liquid VEGF antagonist formulations
#149Methods and formulations for treating sialic acid deficiencies
#150SYNTHETIC GLYCOAMINE COMPOUNDS
#151Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
#152Maternal sialic acid supplementation
#153NGNA compositions and methods of use
#154Methods and formulations for treating sialic acid deficiencies
#155ZINC OXIDE/ACID CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION
#156ACUTE COGNITIVE AND MOOD EFFECTS OF PLANT POLYSACCHARIDES IN ADULT HUMAN SUBJECTS
#157THERAPEUTIC PHARMACEUTICAL AGENT FOR DISEASES ASSOCIATED WITH DECREASE IN FUNCTION OF GNE PROTEIN, FOOD COMPOSITION, AND FOOD ADDITIVE
#158EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
#159Stable liquid VEGF antagonist formulations
#160Medicinal carbohydrates for treatment of respiratory conditions
#161HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS
#162Dimer VEGF antagonist formulations
#163Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
#164INHIBITION OF FATTY ACID SYNTHESIS BY IODO-NITROBENZAMIDE COMPOUNDS AND METHODS OF TREATMENT THEREOF
#165Use of lactulose in the treatment of autism
#166Methods of Treatment
#167Synthesis of high molecular weight iron-saccharidic complexes
#168Formulations for enhanced bioavailability of orally administered polar agents
#169Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
#170Sialic acid to support the immune system in the elderly
#171ANTIADHESIVE CARBOHYDRATES
#172Sucralose Formulations To Mask Unpleasant Tastes
#173HYDRAZIDE-CONTAINING CFTR INHIBITOR COMPOUNDS AND USES THEREOF
#174Hydroxyethyl Starch-Containing Polypeptide Compositions
#175Stabilized compositions of proteins having a free thiol moeity
#176Glycan-based drugs, therapies and biomarkers
#177Carrier particles for use in dry powder inhalers
#178Triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
#179Nanocell Drug Delivery System
#180COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF HELICOBACTER PYLORI INFECTION
#181PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE
#182VEGF antagonist formulations
#183NANOCELL DRUG DELIVERY SYSTEM
#184N-acetyl mannosamine as a therapeutic agent
#185Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar
#186Substrate reduction therapy
#187Compositions and methods of treating viral infections
#188Synthetic N-linked sialo-glycan-containing polymer and method for producing the same
#189Lyophilized formulations of anti-egfr antibodies
#190METHOD FOR PRODUCING COMPOSITION CONTAINING SIALIC ACID COMPOUND
#191Therapeutic agent for pain disease
#192NGNA COMPOSITIONS AND METHODS OF USE
#193Compositions and methods for therapeutic delivery with frozen particles
#194Compositions and methods for therapeutic delivery with frozen particles
#195Pharmaceutical Formulations
#196Compositions for the treatment of chronic degenerative inflammatory conditions
#197EPITOPE REDUCTION THERAPY
#198Salivary substitute
#199Mouse model and treatment of hereditary inclusion body myopathy
#200Systems and processes for spray drying hydrophobic and hydrophilic components
#201Equol production accelerating composition
#202NGNA compositions and methods of use
#203Combination of erythropoietin glycoisoforms
#204HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS
#205HUMAN CHORIONIC GONADOTROPIN (hCG) FORMULATIONS FOR FACILITATING WEIGHT LOSS AND BODY CONTOURING
#206GLYCOMIMETIC INHIBITORS OF SIGLEC-8
#207EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
#208Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
#209Hydrazide-containing CFTR inhibitor compounds and uses thereof
#210Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
#211Compositions of Plant Carbohydrates as Dietary Supplements
#212USE OF LACTULOSE IN THE TREATMENT OF AUTISM
#213Healing powder and method of use thereof
#214Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds
#215PHARMACEUTICAL COMBINATIONS FOR LIPID MANAGEMENT AND IN THE TREATMENT OF ATHEROSCLEROSIS AND HEPATIC STEATOSIS
#216Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
#217Dietary supplements containing anthocyanins and methods for using same to enhance creatine absorption and vasodilation
#218USE OF LACTULOSE IN THE TREATMENT OF AUTISM
#219Composition and method for treatment of hepatic encephalopathy
#220Food product containing policosanols
#221Healing powder and method of use thereof
#222Formulations for ecallantide
#223Antistress agent
#224GRF-containing lyophilized pharmaceutical compositions
#225Stabilized compositions of proteins having a free thiol moiety
#226Pharmaceutical Formulation and Process
#227A DEVICE FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES
#228COMPOSITIONS OF PLANT CARBOHYDRATES AS DIETARY SUPPLEMENTS
#229Thrombin compositions
#230Methods of reducing aggregation of IL-1ra
#231Sialidase inhibitors for the treatment of cardiovascular disease
#232Stable oxaliplatin formulation
#233Antiadhesive carbohydrates
#234Nanocell drug delivery system
#235Methods for preserving nucleated mammalian cells
#236Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring
#237Novel pharmaceutical granulate
#238Glucuronidated nebivolol metabolites
#239STABLE DESLORATADINE COMPOSITIONS
#240Diluent for immunohistochemistry
#241Use of derivatives of succinate esters for the treatment of dementia
#242Composition for nkt cell activation
#243Purgative composition and uses thereof
#244Pharmaceutical formulations comprising magnesium stearate
#245VEGF antagonist formulations
#246Pharmaceutical formulations
#247NGNA compositions and methods of use
#248GRF-containing lyophilized pharmaceutical compositions
#249Formulations for IL-11
#250High affinity receptors for helicobacter pylori and use thereof
#251Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
#252Sucralose formulations to mask unpleasant tastes
#253Methods and compositions for administration of iron for the treatment of restless leg syndrome
#254Lyophilized liposome formulations and method
#255Antiadhesive carbohydrates
#256Isopycnic pharmaceutical formulation
#257Hydroxyethyl starch-containing polypeptide compositions
#258Stable pegylated interferon formulation
#259Compositions containing 5-amino-2-hydroxybenzoic acid and a reducing sugar
#260Antibacterial compositions for drug administration
#261Pharmaceutical formulations and methods
#262Preserved fusogenic vesicles
#263Absorption enhancers for drug administration
#264Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
#265Carrier particles for use in dry powder inhalers
#266Stable particle formulations of erythropoietin receptor agonists
#267Cancer treatment including glycolytic inhibitors
#268Disintegrant assisted controlled release technology
#269Thrombin compositions
#270IL-1ra variants
#271Methods of reducing aggregation of IL-1ra
#272Nanocell drug delivery system
#273Hydrazide-containing CFTR inhibitor compounds and uses thereof
#274Method for normalizing insulin levels
#275Therapeutic agent of skin diseases
#276Composition and method for treatment of hepatic encephalopathy
#277Method and composition for the treatment of adenoviral ocular infections
#278Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
#279Cancer treatment including glycolytic inhibitors
#280Rapidly disintegrating antihistamine formulation
#281Synthesis of high molecular weight iron-saccharidic complexes
#282Cells and method for preserving cells
#283Compositions of plant carbohydrates as dietary supplements
#284Calcium gluconate solutions in flexible containers